Rethinking Evaluation of Multiple Sclerosis Lesion Segmentation Models

A new research paper submitted to arXiv proposes a critical reevaluation of how deep learning models for Multiple Sclerosis (MS) lesion segmentation are assessed. While current state-of-the-art models primarily rely on the Dice score for evaluation, this metric often fails to account for lesion-wise detection performance or complex cases crucial for clinical decision-making. The authors argue that early detection and precise monitoring of MS progression are vital, as existing treatments only slow disease advancement. To address these gaps, the study introduces 'problem fingerprinting,' a method detailing what neurologists specifically look for in brain MRI scans. It identifies necessary metrics to accurately quantify model performance in real-world clinical contexts. Furthermore, the paper presents an analysis of existing models on two open-source datasets using these proposed metrics. The goal is to highlight the usability and reliability of these AI tools for actual deployment in hospitals, ensuring they meet the rigorous standards required for effective disease detection and patient monitoring.